Arteriosclerosis and Thrombosis, Vol 13, 105-111, Copyright © 1993 by American Heart Association
ARTICLES |
Regulation of factor VIIa/tissue factor functional activity in an umbilical vein model
FE Almus, LV Rao and SI Rapaport
Department of Medicine, University of California, San Diego, School of Medicine, La Jolla.
Activation of factor IX in an umbilical vein model was established to result solely from factor VIIa/tissue factor (TF) activity generated within the umbilical vein wall, and the model was then used to study regulation of such extravascular factor VIIa-TF complexes. Vein segments were filled with a reaction mixture containing factor VIIa, Ca2+, a substrate, either [3H]factor IX or [3H]factor X, and a test material. Subsamples were assayed for activation peptide release. Test materials included defibrinated plasma or recombinant protein as a source of TF pathway inhibitor (TFPI), recombinant factor VIIa to 10 times plasma factor VII concentrations, and annexin V. A plasma concentration of TFPI inhibited but did not totally suppress factor VIIa/TF activity. Reducing the TFPI concentration by 50% markedly reduced the inhibition. A 10-fold increase in the factor VIIa concentration in reaction mixtures failed to accelerate factor Xa generation. Annexin V, in contrast to its inhibition of factor VIIa/TF formed with TF reconstituted into mixed phospholipid vesicles, failed to inhibit factor VIIa-TF complexes formed within the vessel wall. We conclude that 1) moderate variation in plasma TFPI concentration or activity may affect TFPI's ability to inhibit factor VIIa/TF activity during hemostasis, 2) a plasma concentration of factor VII suffices to saturate TF sites exposed in a vessel after tissue injury, and 3) the resistance of factor VIIa-TF complexes to inhibition by annexin V suggests that they are formed in the umbilical vein model primarily on cell surfaces.
This article has been cited by other articles:
 |
|
 |
|
  M. Jayachandran, A. Sanzo, W. G. Owen, and V. M. Miller Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1908 - H1916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Samad, M. Pandey, and D. J. Loskutoff Regulation of tissue factor gene expression in obesity Blood, December 1, 2001; 98(12): 3353 - 3358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-B. Hansen, R. Olsen, and P. Webster Association of Tissue Factor Pathway Inhibitor With Human Umbilical Vein Endothelial Cells Blood, November 1, 1997; 90(9): 3568 - 3578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-B. Hansen, K. R. Huseby, N.-E. Huseby, P. M. Sandset, T.-A. Hanssen, and A. Nordoy Effect of Cholesterol Lowering on Intravascular Pools of TFPI and Its Anticoagulant Potential in Type II Hyperlipoproteinemia Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 879 - 885. [Abstract] [Full Text]
|
|